Menkes Disease Severity Score and Copper Histidinate Response

Assesses Menkes disease severity using copper and ceruloplasmin levels, neurological development score, connective tissue findings, and subcutaneous copper histidinate response in mutation-specific outcome prediction

Each component has a specific meaning:

• Copper — The copper recorded for the scenario being assessed.
• Ceruloplasmin levels — The ceruloplasmin levels recorded for the scenario being assessed.
• Connective tissue findings — The connective tissue findings recorded for the scenario being assessed.
• Subcutaneous copper histidinate response in mutation-specific outcome prediction — The subcutaneous copper histidinate response in mutation-specific outcome prediction recorded for the scenario being assessed.

Note: Interpret the menkes disease score result against the thresholds and context described above.

Enter the copper, ceruloplasmin levels, connective tissue findings, subcutaneous copper histidinate response in mutation-specific outcome prediction for the scenario you are assessing. Assesses Menkes disease severity using copper and ceruloplasmin levels, neurological development score, connective tissue findings, and subcutaneous copper histidinate response in mutation-specific outcome prediction. Use the menkes disease score result to inform your calculation.